ClinicalTrials.Veeva

Menu

Oxytocin and Emotion Processing

U

University Hospital Bonn (UKB)

Status and phase

Completed
Phase 1

Conditions

Healthy Males

Treatments

Drug: Oxytocin

Study type

Interventional

Funder types

Other

Identifiers

NCT02156661
OXT-FC-14

Details and patient eligibility

About

The purpose of this study is to determine whether oxytocin influences emotional processing and learning of emotional and social stimuli.

Full description

An effect of OXT on emotion processing and anxiety has been broadly investigated in animal studies. However, in humans, effects seem more complex.

The rationale of the study is to examine direct effects of OXT to processing and learning of emotional and social values in humans.

Enrollment

97 patients

Sex

Male

Ages

20 to 40 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Healthy male volunteers

Exclusion criteria

  • Current or past psychiatric disease
  • Current or past physical illness
  • Psychoactive medication
  • Tobacco smokers
  • MRI contraindication

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

97 participants in 2 patient groups, including a placebo group

Oxytocin
Active Comparator group
Description:
Oxytocin: Syntocinon-Spray, Novartis intranasal administration, 24 IU oxytocin; ; 3 puffs per nostril, each with 4 IU OXT
Treatment:
Drug: Oxytocin
Placebo
Placebo Comparator group
Description:
Placebo nasal spray
Treatment:
Drug: Oxytocin

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems